Featured News
news cover
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
30 Nov 2025
news cover
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096
30 Nov 2025
news cover
Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC
30 Nov 2025
news cover
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
28 Nov 2025
View more
Global Express
7 hours ago
As New Hereditary Angioedema Drugs Flood the Market, Will Uptake Match Innovation?
Phase 3Drug ApprovalClinical ResultPhase 2
7 hours ago
FDA Action Alert: BMS, GSK, Amgen and More
Phase 3Clinical ResultDrug ApprovalPhase 2Cell Therapy
17 hours ago
US FDA memo links 10 child deaths to COVID vaccines
VaccineEmergency Use AuthorizationmRNA
20 hours ago
Codeine syrup syndicate: FIR filed against 12 more firms
30 Nov 2025
FDA set to tighten vaccine regulation amid claims that COVID-19 shots killed at least 10 kids
VaccineExecutive ChangemRNA
View more
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Hot reports
May 2025 Patent Highlights
May 2025 Patent Highlights
Patsnap Synapse
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
Patsnap Synapse
Global Drug R&D Express (February 2025)
Global Drug R&D Express (February 2025)
PatSnap Synapse
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.